Cargando…

Serotonin promotes the proliferation of serum-deprived hepatocellular carcinoma cells via upregulation of FOXO3a

BACKGROUND: Peripheral serotonin is involved in tumorigenesis and induces a pro-proliferative effect in hepatocellular carcinoma (HCC) cells; however, the intracellular mechanisms by which serotonin exerts a mitogenic effect remain unclear. In this research, we examined whether FOXO3a, a transcripti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Chao, Chen, Wei, Zhi, Xiao, Ma, Tao, Xia, Xuefeng, Liu, Hao, Zhang, Qi, Hu, Qida, Zhang, Yun, Bai, Xueli, Liang, Tingbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601970/ https://www.ncbi.nlm.nih.gov/pubmed/23418729 http://dx.doi.org/10.1186/1476-4598-12-14

Ejemplares similares

Salinomycin decreases doxorubicin resistance in hepatocellular carcinoma cells by inhibiting the β-catenin/TCF complex association via FOXO3a activation
por: Zhou, Yue, et al.
Publicado: (2015)

Upregulator of Cell Proliferation Predicts Poor Prognosis in Hepatocellular Carcinoma and Contributes to Hepatocarcinogenesis by Downregulating FOXO3a
por: Xie, Chan, et al.
Publicado: (2012)

Evaluation of Intra-Tumoral Vascularization in Hepatocellular Carcinomas
por: Zhang, Qi, et al.
Publicado: (2020)

Immune Checkpoint Blockade Therapy for Hepatocellular Carcinoma: Clinical Challenges and Considerations
por: Zhang, Qi, et al.
Publicado: (2020)

A preoperative nomogram predicts prognosis of patients with hepatocellular carcinoma after liver transplantation: a multicenter retrospective study
por: Huang, Dabing, et al.
Publicado: (2021)

OSI-027 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine both in vitro and in vivo
por: Zhi, Xiao, et al.
Publicado: (2015)

A Seven-Gene Signature to Predict Prognosis of Patients With Hepatocellular Carcinoma
por: Wang, Junli, et al.
Publicado: (2021)

Regulation of Multi-drug Resistance in hepatocellular carcinoma cells is TRPC6/Calcium Dependent
por: Wen, Liang, et al.
Publicado: (2016)

Integrative analysis identified two subtypes and a taurine-related signature to predict the prognosis and efficacy of immunotherapy in hepatocellular carcinoma
por: Lu, Qingsong, et al.
Publicado: (2023)

Molecular Profiling–Based Precision Medicine in Cancer: A Review of Current Evidence and Challenges
por: Zhang, Qi, et al.
Publicado: (2020)

Eating self for not be eaten: Pancreatic cancer suppresses self-immunogenicity by autophagy-mediated MHC-I degradation
por: Huang, Xing, et al.
Publicado: (2020)

Reviving the role of MET in liver cancer therapy and vaccination: an autophagic perspective
por: Huang, Xing, et al.
Publicado: (2020)

Combinational therapy targeting the MET‐mTOR‐ROS loop disrupts mitochondrial autoregulatory machinery of liver cancer
por: Huang, Xing, et al.
Publicado: (2020)

Targeting TNFR2: A Novel Breakthrough in the Treatment of Cancer
por: Li, Muchun, et al.
Publicado: (2022)

O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy
por: Lu, Qingsong, et al.
Publicado: (2022)

MicroRNA-1269 promotes proliferation in human hepatocellular carcinoma via downregulation of FOXO1
por: Yang, Xue-Wei, et al.
Publicado: (2014)

Upregulation of FOXO1 contributes to lipopolysaccharide-induced pulmonary endothelial injury by induction of autophagy
por: Zhao, Ying, et al.
Publicado: (2022)

Demethylation at enhancer upregulates MCM2 and NUP37 expression predicting poor survival in hepatocellular carcinoma patients
por: Tang, Zengwei, et al.
Publicado: (2022)

Salvage Liver Transplant versus Primary Liver Transplant for Patients with Hepatocellular Carcinoma
por: Yadav, Dipesh Kumar, et al.
Publicado: (2018)

Correction: Demethylation at enhancer upregulates MCM2 and NUP37 expression predicting poor survival in hepatocellular carcinoma patients
por: Tang, Zengwei, et al.
Publicado: (2022)

TRIM11 Upregulation Contributes to Proliferation, Invasion, and EMT of Hepatocellular Carcinoma Cells
por: Zhang, Zewei, et al.
Publicado: (2017)

Multiplex imaging reveals the architecture of the tumor immune microenvironment
por: Zhang, Junlei, et al.
Publicado: (2021)

Human endogenous retrovirus-H long terminal repeat-associating 2: The next immune checkpoint for antitumour therapy
por: Ying, Honggang, et al.
Publicado: (2022)

RCAN1-mediated calcineurin inhibition as a target for cancer therapy
por: Lao, Mengyi, et al.
Publicado: (2022)

Upregulation of miR-96 Enhances Cellular Proliferation of Prostate Cancer Cells through FOXO1
por: Haflidadóttir, Benedikta S., et al.
Publicado: (2013)

An Ionic Liquid Ablation Agent for Local Ablation and Immune Activation in Pancreatic Cancer
por: Huang, Junming, et al.
Publicado: (2023)

Sintilimab-Induced Autoimmune Diabetes in a Patient With the Anti-tumor Effect of Partial Regression
por: Wen, Liang, et al.
Publicado: (2020)

KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a
por: Huang, L, et al.
Publicado: (2013)

Liver Transplantation for Alcohol-Related Liver Disease (ARLD): An Update on Controversies and Considerations
por: Yadav, Dipesh Kumar, et al.
Publicado: (2020)

Glucose Metabolism: The Metabolic Signature of Tumor Associated Macrophage
por: Zhang, Qi, et al.
Publicado: (2021)

Acute sleep deprivation upregulates serotonin 2A receptors in the frontal cortex of mice via the immediate early gene Egr3
por: Zhao, Xiuli, et al.
Publicado: (2022)

Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma
por: Liao, Weijia, et al.
Publicado: (2015)

Hypoxia induces sorafenib resistance mediated by autophagy via activating FOXO3a in hepatocellular carcinoma
por: Liang, Chao, et al.
Publicado: (2020)

Surgical resection and outcome of pancreatic cystic neoplasms in China: analysis of a 16-year experience from a single high-volume academic institution
por: Bai, Xueli, et al.
Publicado: (2014)

Outcomes of liver transplantation using moderately steatotic liver from donation after cardiac death (DCD)
por: Duan, Xin, et al.
Publicado: (2020)

Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy
por: Tang, Tianyu, et al.
Publicado: (2021)

Gallbladder Adenosquamous Cancer with Situs Inversus Totalis: A Case Report and Literature Review
por: Huang, Junming, et al.
Publicado: (2021)

Engineered a dual-targeting biomimetic nanomedicine for pancreatic cancer chemoimmunotherapy
por: Wang, Meng, et al.
Publicado: (2022)

Epigenetic dysregulation-mediated COL12A1 upregulation predicts worse outcome in intrahepatic cholangiocarcinoma patients
por: Tang, Zengwei, et al.
Publicado: (2023)

Neoadjuvant modified-FOLFIRINOX followed by surgical resection of both the primary and metastatic tumors of a pancreatic hepatoid carcinoma with synchronous liver metastasis: A case report
por: Ma, Tao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_klom60ghnsmv8epv6ud29ssdiu